PROSIEBENSAT1 MED. (PBSFF) Given Consensus Rating of “Hold” by Brokerages
PROSIEBENSAT1 MED. (OTCMKTS:PBSFF) has been assigned an average rating of “Hold” from the six ratings firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company.
PBSFF has been the topic of a number of research reports. Citigroup Inc. reiterated a “neutral” rating on shares of PROSIEBENSAT1 MED. in a report on Tuesday, May 9th. BNP Paribas lowered shares of PROSIEBENSAT1 MED. from an “outperform” rating to a “neutral” rating in a report on Friday, July 7th.
Shares of PROSIEBENSAT1 MED. (OTCMKTS:PBSFF) traded down 13.52% on Friday, reaching $33.53. The company had a trading volume of 100 shares. The firm has a market capitalization of $7.67 billion and a price-to-earnings ratio of 15.21. PROSIEBENSAT1 MED. has a 52 week low of $33.53 and a 52 week high of $44.80. The stock’s 50 day moving average is $39.15 and its 200 day moving average is $41.30.
PROSIEBENSAT1 MED. Company Profile
Receive News & Stock Ratings for PROSIEBENSAT1 MED. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROSIEBENSAT1 MED. and related stocks with our FREE daily email newsletter.